• NewAmsterdam Pharma (NASDAQ:NAMS) Issues Earnings Results, Misses Estimates By $0.47 EPS

    Source: Buzz FX / 27 Feb 2025 14:56:19   America/New_York


    NewAmsterdam Pharma (NASDAQ:NAMS) Issues Earnings Results, Misses Estimates By $0.47 EPS Written by MarketBeat February 27, 2025 Share Link copied to clipboard. NewAmsterdam Pharma ( NASDAQ:NAMS - Get Free Report ) announced its quarterly e
    Read more...
Share on,